Prosecution Insights
Last updated: October 02, 2026

Examiner: LALONDE, ALEXANDRA ELIZABETH

Tech Center 3700 • Art Units: 3763 3783

This examiner grants 71% of resolved cases

Analysis

Alexandra Elizabeth Lalonde, in Tech Center 3700 and Art Unit 3763, has 394 resolved cases. Her allowance rate pct of 71.1 suggests the prosecution environment for applications. The median days to allowance is 1237, indicating the duration for reaching a grant. This 1237-day timeline provides an expectation for applicants navigating Art Unit 3763 and planning their prosecution budgets.

The interview lift pct of 33.0 is a metric suggesting that interviews are a component of a successful strategy with this examiner. This 33.0 lift indicates that verbal advocacy can improve the 71.1 allowance rate pct. For the 394 resolved cases on record, the data supports the use of interviews to move applications toward allowance. An interview lift pct of 33.0 is a reason for practitioners to engage in direct dialogue to resolve outstanding rejections and potentially shorten the 1237-day median pendency.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

71.1%
Allow Rate
+1.1% vs TC avg
429
Total Applications
+33.0%
Interview Lift
1237
Avg Prosecution Days
Based on 394 resolved cases, 2023–2026

Rejection Statute Breakdown

0.3%
§101 Eligibility
20.4%
§102 Novelty
41.7%
§103 Obviousness
34.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17479883 PRESSURE RELEASE FOR MEDICAL DEVICES Final Rejection Boston Scientific Scimed, Inc.
18116232 Guidewires and Assemblies for Automatic Withdrawal of Stylets and Methods Thereof Final Rejection Bard Access Systems, Inc.
18081480 Acute Central Venous Catheter Symmetric Filler Non-Final OA Bard Access Systems, Inc.
18543386 Control of Irrigation in a Phacoemulsification System Non-Final OA JOHNSON & JOHNSON SURGICAL VISION, INC.
18488392 ANTIMICROBIAL INTRAVENOUS SET Non-Final OA CareFusion 303, Inc.
17519191 ANTI-SNAGGING INFUSION SETS Non-Final OA CareFusion 303, Inc.
17392847 DEVICES AND METHODS FOR TREATING A STRICTURE ALONG THE BILIARY AND/OR PANCREATIC TRACT Final Rejection NORTHWESTERN UNIVERSITY
18266907 OVAL PLUNGER PISTON WITHO-RING PRESSURE EQUALIZING CHANNELS FOR IMPROVED LEAK PERFORMANCE Final Rejection Becton, Dickinson and Company
18099541 Systems and Methods for Adjusting the Length of Line Draw Lever Lock Components for Compatibility With Various Length Peripheral Intravenous Catheters (PIVC) Final Rejection Becton, Dickinson and Company
18782551 MEDICAMENT DELIVERY DEVICE HAVING AN ACTIVATING MECHANISM Non-Final OA Sanofi
18804706 ENDOSCOPIC PUNCTURE NEEDLE UNIT Non-Final OA The University of Tokyo
18729946 Feedback mechanism Non-Final OA SHL Medical AG
18196506 IMPLANTABLE MEDICAL DEVICE AND SYSTEM Non-Final OA Biogen MA Inc.
18070029 IMPLANTABLE INTRAVENTRICULAR SAMPLING AND INFUSION ACCESS DEVICE Non-Final OA BIOGEN MA Inc.
17955025 INSTRUMENT CONNECTION DEVICE AND METHOD FOR PRODUCTION THEREOF Final Rejection Erbe Elektromedizin GmbH
17277533 PLATFORM ASSEMBLY PROCESS FOR DRUG DELIVERY DEVICE Final Rejection AMGEN INC.
17036690 DRUG DELIVERY DEVICE Non-Final OA AMGEN INC.
18719845 LIQUID MEDICINE INJECTION APPARATUS Non-Final OA EOFLOW CO., LTD.
18713519 MEDICAL DEVICE FOR THE TARGETED APPLICATION OF A THERAPEUTIC AGENT TO THE ROUND WINDOW OF THE COCHLEA Non-Final OA INSTITUT PASTEUR
17766956 KEYED CONNECTORS FOR MEDICAMENT DELIVERY DEVICES Final Rejection HASELMEIER AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month